Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.
...
Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, an...
Institut Gustave Roussy, Villejuif, France
St. Anna Children's Hospital, Vienna, Austria
Kinderklinik, Giessen, Germany
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
St. Vincent's Comprehensive Cancer Center - Manhattan, New York, New York, United States
Northside Hospital Cancer Center, Atlanta, Georgia, United States
Center for Molecular Medicine, Garden City, New York, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Institute of Hematology & Transfusiology, University Hospital, Bratislava, Slovakia
Hopital Universitaire Erasme, Brussels, Belgium
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Children's Oncology Group, Arcadia, California, United States
Children's Oncology Group, Arcadia, California, United States
Genta Incorporated, Berkeley Heights, New Jersey, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.